Global CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Region: Trend Forecast and Growth Opportunity

February 2022 | 180 pages | ID: GC5D69B8A2C5EN
GMD Research

Abstracts

Global CRISPR gene editing market will reach $16,329.8 million by 2031, growing by 26.4% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.

Highlighted with 87 tables and 86 figures, this 180-page report “Global CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global CRISPR gene editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global CRISPR gene editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Region.

Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• CRISPR Products
• Kits & Enzymes
• Vector-Based Cas9
• DNA-Free Cas9
• Databases & Libraries
• Design Tools
• Antibodies
• CRISPR Plasmid & Vector
• Other Products
• CRISPR Services
• gRNA Design & Vector Construction
• Cell Line Engineering
• Microbial Gene Editing
• DNA Synthesis
• Other Services

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Biomedical Research & Therapy
• Gene Therapy
• Drug Discovery
• Diagnostics
• Other Biomedical Applications
• Agriculture
• Industrial Use
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutions & Research Centers
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Switzerland, Russia, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Offering, Application, and End User, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abcam, Inc.

Agilent Technologies, Inc.

Applied StemCell, Inc.

Caribou Biosciences, Inc.

Cellecta, Inc.

CRISPR Therapeutics AG

Editas Medicine, Inc.

GeneCopoeia, Inc.

GeneScript Biotech Corporation

Horizon Discovery Group PLC

Integrated DNA Technologies, Inc.

Intellia Therapeutics Inc.

Lonza Group Ltd.

Merck KGaA

New England Biolabs, Inc.

Origene Technologies, Inc.

Rockland Immunochemicals, Inc.

Synthego Corporation

System Biosciences LLC

Takara Bio, Inc.

Thermo Fisher Scientific, Inc.

ToolGen, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY OFFERING

3.1 Market Overview by Offering
3.2 CRISPR Products
  3.2.1 Kits & Enzymes
  3.2.2 Databases & Libraries
  3.2.3 Design Tools
  3.2.4 Antibodies
  3.2.5 CRISPR Plasmid & Vector
  3.2.6 Other Products
3.3 CRISPR Services
  3.3.1 gRNA Design & Vector Construction
  3.3.2 Cell Line Engineering
  3.3.3 Microbial Gene Editing
  3.3.4 DNA Synthesis
  3.3.5 Other Services

4 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

4.1 Market Overview by Application
4.2 Biomedical Research & Therapy
  4.2.1 Gene Therapy
  4.2.2 Drug Discovery
  4.2.3 Diagnostics
  4.2.4 Other Biomedical Applications
4.3 Agriculture
4.4 Industrial Use
4.5 Other Applications

5 SEGMENTATION OF GLOBAL MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical Companies
5.3 Biotechnology Companies
5.4 Academic Institutions & Research Centers
5.5 Other End Users

6 SEGMENTATION OF GLOBAL MARKET BY REGION

6.1 Geographic Market Overview 2021-2031
6.2 North America Market 2021-2031 by Country
  6.2.1 Overview of North America Market
  6.2.2 U.S.
  6.2.3 Canada
  6.2.4 Mexico
6.3 European Market 2021-2031 by Country
  6.3.1 Overview of European Market
  6.3.2 Germany
  6.3.3 U.K.
  6.3.4 France
  6.3.5 Spain
  6.3.6 Italy
  6.3.7 Netherlands
  6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2021-2031 by Country
  6.4.1 Overview of Asia-Pacific Market
  6.4.2 Japan
  6.4.3 China
  6.4.4 Australia
  6.4.5 India
  6.4.6 South Korea
  6.4.7 Rest of APAC Region
6.5 South America Market 2021-2031 by Country
  6.5.1 Argentina
  6.5.2 Brazil
  6.5.3 Chile
  6.5.4 Rest of South America Market
6.6 MEA Market 2021-2031 by Country
  6.6.1 UAE
  6.6.2 Saudi Arabia
  6.6.3 South Africa
  6.6.4 Other National Markets

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global CRISPR Gene Editing Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Developing Roadmap of CRISPR Technology
Table 4. Private and Public Companies Investment in CRISPR Technology
Table 5. Comparison of CRISPR with Other Gene Editing Technologies
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global CRISPR Gene Editing Market
Table 8. Global CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 9. Global CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn
Table 10. Global CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn
Table 11. Global CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn
Table 12. Global CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 13. Global CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn
Table 14. Global CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 15. Global CRISPR Gene Editing Market by Region, 2021-2031, $ mn
Table 16. Leading National CRISPR Gene Editing Market, 2021 and 2031, $ mn
Table 17. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 18. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 19. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 20. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 21. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 22. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 23. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 24. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 25. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 26. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 27. Europe CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 28. Germany CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 29. Germany CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 30. Germany CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 31. U.K. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 32. U.K. CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 33. U.K. CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 34. France CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 35. France CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 36. France CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 37. Spain CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 38. Spain CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 39. Spain CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 40. Italy CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 41. Italy CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 42. Italy CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 43. Netherlands CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 44. Netherlands CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 45. Netherlands CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 46. CRISPR Gene Editing Market in Rest of Europe by Country, 2021-2031, $ mn
Table 47. APAC CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 48. Japan CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 49. Japan CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 50. Japan CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 51. China CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 52. China CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 53. China CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 54. Australia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 55. Australia CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 56. Australia CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 57. India CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 58. India CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 59. India CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 60. South Korea CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 61. South Korea CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 62. South Korea CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 63. CRISPR Gene Editing Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 64. South America CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 65. Argentina CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 66. Argentina CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 67. Argentina CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 68. Brazil CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 69. Brazil CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 70. Brazil CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 71. Chile CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 72. Chile CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 73. Chile CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 74. MEA CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 75. UAE CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 76. UAE CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 77. UAE CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 78. Saudi Arabia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 79. Saudi Arabia CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 80. Saudi Arabia CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 81. South Africa CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 82. South Africa CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 83. South Africa CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 84. Breakdown of World Market by Key Vendor, 2021, %
Table 85. Abcam, Inc.: Company Snapshot
Table 86. Abcam, Inc.: Business Segmentation
Table 87. Abcam, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 5. Categories of CRISPR-Cas Systems
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global CRISPR Gene Editing Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global CRISPR Gene Editing Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global CRISPR Gene Editing Market
Figure 14. Breakdown of Global CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue
Figure 15. Global Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)
Figure 16. Global CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn
Figure 17. Global CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn
Figure 18. Global CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn
Figure 19. Global CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn
Figure 20. Global CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn
Figure 21. Global CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn
Figure 22. Global CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn
Figure 23. Global CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn
Figure 24. Global CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn
Figure 25. Global CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn
Figure 26. Global CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn
Figure 27. Global CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn
Figure 28. Global CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn
Figure 29. Breakdown of Global CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue
Figure 30. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 31. Global CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn
Figure 32. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn
Figure 33. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn
Figure 34. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn
Figure 35. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn
Figure 36. Global CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn
Figure 37. Global CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn
Figure 38. Global CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn
Figure 39. Breakdown of Global CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue
Figure 40. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 41. Global CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn
Figure 42. Global CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn
Figure 43. Global CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn
Figure 44. Global CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn
Figure 45. Global Market Snapshot by Region
Figure 46. Geographic Spread of Worldwide CRISPR Gene Editing Market, 2021-2031, % of Sales Revenue
Figure 47. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 48. North American CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 49. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 50. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 51. U.S. CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 52. Canada CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 53. CRISPR Gene Editing Market in Mexico, 2021-2031, $ mn
Figure 54. European CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 55. Breakdown of European CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 56. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. CRISPR Gene Editing Market in Germany, 2021-2031, $ mn
Figure 58. CRISPR Gene Editing Market in U.K., 2021-2031, $ mn
Figure 59. CRISPR Gene Editing Market in France, 2021-2031, $ mn
Figure 60. CRISPR Gene Editing Market in Spain, 2021-2031, $ mn
Figure 61. CRISPR Gene Editing Market in Italy, 2021-2031, $ mn
Figure 62. CRISPR Gene Editing Market in Netherlands, 2021-2031, $ mn
Figure 63. CRISPR Gene Editing Market in Rest of Europe, 2021-2031, $ mn
Figure 64. Asia-Pacific CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 65. Breakdown of APAC CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 66. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 67. CRISPR Gene Editing Market in Japan, 2021-2031, $ mn
Figure 68. CRISPR Gene Editing Market in China, 2021-2031, $ mn
Figure 69. CRISPR Gene Editing Market in Australia, 2021-2031, $ mn
Figure 70. CRISPR Gene Editing Market in India, 2021-2031, $ mn
Figure 71. CRISPR Gene Editing Market in South Korea, 2021-2031, $ mn
Figure 72. CRISPR Gene Editing Market in Rest of APAC, 2021-2031, $ mn
Figure 73. South America CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 74. Breakdown of South America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 75. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 76. CRISPR Gene Editing Market in Argentina, 2021-2031, $ mn
Figure 77. CRISPR Gene Editing Market in Brazil, 2021-2031, $ mn
Figure 78. CRISPR Gene Editing Market in Chile, 2021-2031, $ mn
Figure 79. CRISPR Gene Editing Market in Rest of South America, 2021-2031, $ mn
Figure 80. CRISPR Gene Editing Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 81. Breakdown of MEA CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 82. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 83. CRISPR Gene Editing Market in UAE, 2021-2031, $ mn
Figure 84. CRISPR Gene Editing Market in Saudi Arabia, 2021-2031, $ mn
Figure 85. CRISPR Gene Editing Market in South Africa, 2021-2031, $ mn
Figure 86. Growth Stage of Global CRISPR Gene Editing Industry over the Forecast Period